Self-reported Cumulative Medical Opioid Exposure and Subjective Responses on First Use of Opioids Predict Analgesic and Subjective Responses to Placebo-controlled Opioid Administration

Overview

Journal Reg Anesth Pain Med

Date 2019 Jan 15

PMID 30640659

Citations 5

Authors

Stephen Bruehl

Amanda L Stone

Cassandra Palmer

David A Edwards

Asokumar Buvanendran

Rajnish Gupta

Melissa Chont

Mary Kennedy

John W Burns

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: To expand the evidence base needed to enable personalized pain medicine, we evaluated whether self-reported cumulative exposure to medical opioids and subjective responses on first opioid use predicted responses to placebo-controlled opioid administration.

Methods: In study 1, a survey assessing cumulative medical opioid exposure and subjective responses on first opioid use was created (History of Opioid Medical Exposure (HOME)) and psychometric features documented in a general sample of 307 working adults. In study 2, 49 patients with chronic low back pain completed the HOME and subsequently rated back pain intensity and subjective opioid effects four times after receiving saline placebo or intravenous morphine (four incremental doses) in two separate double-blinded laboratory sessions. Placebo-controlled morphine effects were derived for all outcomes.

Results: Two HOME subscales were supported: cumulative opioid exposure and euphoric response, both demonstrating high test-retest reliability (Intraclass Correlation Coefficients > 0.93) and adequate internal consistency (Revelle's Omega Total = 0.73-0.77). In study 2, higher cumulative opioid exposure scores were associated with significantly greater morphine-related reductions in back pain intensity (p=0.02), but not with subjective drug effects. Higher euphoric response subscale scores were associated with significantly lower overall perceived morphine effect (p=0.003), less sedation (p=0.04), greater euphoria (p=0.03) and greater desire to take morphine again (p=0.02).

Discussion: Self-reports of past exposure and responses to medical opioid analgesics may have utility for predicting subsequent analgesic responses and subjective effects. Further research is needed to establish the potential clinical and research utility of the HOME.

Trial Registration Number: NCT02469077.

Citing Articles

Preoperative Predictors of Prolonged Opioid Use in the 6 Months After Total Knee Arthroplasty.

Larach D, Kertai M, Billings 4th F, Anderson S, Polkowski G, Shinar A Clin J Pain. 2023; 39(10):516-523.

PMID: 37440337 PMC: 10529895. DOI: 10.1097/AJP.0000000000001143.

Accelerating Opioid Use Disorders Research by Integrating Multiple Data Modalities.

Bianchi S, Jeffery A, Samuels D, Schirle L, Palmer A, Sanchez-Roige S Complex Psychiatry. 2022; 8(1-2):1-8.

PMID: 36545043 PMC: 9669996. DOI: 10.1159/000525079.

Substance use and common contributors to morbidity: A genetics perspective.

Sanchez-Roige S, Kember R, Agrawal A EBioMedicine. 2022; 83:104212.

PMID: 35970022 PMC: 9399262. DOI: 10.1016/j.ebiom.2022.104212.

Retrospectively assessed subjective effects of initial opioid use differ between opioid misusers with opioid use disorder (OUD) and those who never progressed to OUD: Data from a pilot and a replication sample.

Agrawal A, Jeffries P, Srivastava A, McCutcheon V, Lynskey M, Heath A J Neurosci Res. 2020; 100(1):353-361.

PMID: 32468677 PMC: 8142810. DOI: 10.1002/jnr.24643.

The association between endogenous opioid function and morphine responsiveness: a moderating role for endocannabinoids.

Bruehl S, Burns J, Morgan A, Koltyn K, Gupta R, Buvanendran A Pain. 2018; 160(3):676-687.

PMID: 30562268 PMC: 6377294. DOI: 10.1097/j.pain.0000000000001447.

References

Bieber C, Fernandez K, Borsook D, Brennan M, Butler S, Jamison R . Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study. Exp Clin Psychopharmacol. 2008; 16(5):429-34. PMC: 3153468. DOI: 10.1037/1064-1297.16.5.429. View

Zacny J . Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. Psychopharmacology (Berl). 2002; 165(2):146-56. DOI: 10.1007/s00213-002-1245-5. View

Hill J, Zacny J . Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers. Psychopharmacology (Berl). 2000; 152(1):31-9. DOI: 10.1007/s002130000500. View

Wightman R, Perrone J, Portelli I, Nelson L . Likeability and abuse liability of commonly prescribed opioids. J Med Toxicol. 2012; 8(4):335-40. PMC: 3550270. DOI: 10.1007/s13181-012-0263-x. View

Butler S, Fernandez K, Benoit C, Budman S, Jamison R . Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008; 9(4):360-72. PMC: 2359825. DOI: 10.1016/j.jpain.2007.11.014. View

Walker D, Zacny J . Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers. J Pharmacol Exp Ther. 1999; 289(3):1454-64. View

Comer S, Sullivan M, Vosburg S, Kowalczyk W, Houser J . Abuse liability of oxycodone as a function of pain and drug use history. Drug Alcohol Depend. 2010; 109(1-3):130-8. PMC: 2917813. DOI: 10.1016/j.drugalcdep.2009.12.018. View

Walker D, Zacny J . Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteers. Psychopharmacology (Berl). 1998; 140(2):191-201. DOI: 10.1007/s002130050757. View

Han B, Compton W, Blanco C, Crane E, Lee J, Jones C . Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 2017; 167(5):293-301. DOI: 10.7326/M17-0865. View

10.

Wasan A, Davar G, Jamison R . The association between negative affect and opioid analgesia in patients with discogenic low back pain. Pain. 2005; 117(3):450-461. DOI: 10.1016/j.pain.2005.08.006. View

11.

Amtmann D, Cook K, Jensen M, Chen W, Choi S, Revicki D . Development of a PROMIS item bank to measure pain interference. Pain. 2010; 150(1):173-182. PMC: 2916053. DOI: 10.1016/j.pain.2010.04.025. View

12.

HAERTZEN C . Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI). Psychol Rep. 1966; 18(1):163-94. DOI: 10.2466/pr0.1966.18.1.163. View

13.

Burns J, Bruehl S, France C, Schuster E, Orlowska D, Chont M . Endogenous Opioid Function and Responses to Morphine: The Moderating Effects of Anger Expressiveness. J Pain. 2017; 18(8):923-932. PMC: 5729586. DOI: 10.1016/j.jpain.2017.02.439. View

14.

Edwards R, Dolman A, Michna E, Katz J, Nedeljkovic S, Janfaza D . Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative Affect. Pain Med. 2016; 17(10):1882-1891. PMC: 5063023. DOI: 10.1093/pm/pnw010. View

15.

Brummett C, Janda A, Schueller C, Tsodikov A, Morris M, Williams D . Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplasty: a prospective, observational cohort study. Anesthesiology. 2013; 119(6):1434-43. PMC: 3867739. DOI: 10.1097/ALN.0b013e3182a8eb1f. View

16.

Walsh S, Nuzzo P, Lofwall M, Holtman Jr J . The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers. Drug Alcohol Depend. 2008; 98(3):191-202. PMC: 2668197. DOI: 10.1016/j.drugalcdep.2008.05.007. View

17.

Edwards R, Haythornthwaite J, Tella P, Max M, Raja S . Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia. Anesthesiology. 2006; 104(6):1243-8. DOI: 10.1097/00000542-200606000-00020. View

18.

McNeish D . Thanks coefficient alpha, we'll take it from here. Psychol Methods. 2017; 23(3):412-433. DOI: 10.1037/met0000144. View

19.

Eisenberg E, Midbari A, Haddad M, Pud D . Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects. Pain. 2010; 151(1):104-109. DOI: 10.1016/j.pain.2010.06.025. View

20.

Bruehl S . Personalized pain medicine: pipe dream or reality?. Anesthesiology. 2015; 122(5):967-8. PMC: 4439303. DOI: 10.1097/ALN.0000000000000638. View